1-(3-Bromopyridin-2-yl)piperazine hydrochloride

Catalog No.: 
ACJHLX632
CAS No.: 
85386-85-2
Molecular Formula: 
C9H13BrClN3
Molecular Weight: 
278.58
1-(3-Bromopyridin-2-yl)piperazine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$103.00In stockInquiry
10g95%$180.00In stockInquiry
25g95%$352.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Bromopyridin-2-yl)piperazine hydrochloride
IUPAC Name1-(3-bromopyridin-2-yl)piperazine hydrochloride
Molecular FormulaC9H13BrClN3
Molecular Weight278.58
SMILESBrC1=CC=CN=C1N2CCNCC2.[H]Cl
InChI KeySSQFKKFRVCWWSR-UHFFFAOYSA-N
SynonymPiperazine, 1-(3-bromo-2-pyridinyl)-, hydrochloride (1:1);1-(3-Bromopyridin-2-yl)piperazine hydrochloride;1-(3-Bromopyridin-2-yl)piperazine hydrochloride - [B92986]
CAS No.85386-85-2

Synthetic Route by SureRoute

1. ACJHLX632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHWKJ480 route compound structure diagram
    ACHWKJ4801187386-01-1In Stock
  2. Then
  3. ACJHLX632 route product structure diagram
    ACJHLX63285386-85-2In Stock
Inquiry

2. ACJHLX632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  4. Then
  5. ACJHLX632 route product structure diagram
    ACJHLX63285386-85-2In Stock
Inquiry

3. ACJHLX632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  6. Then
  7. ACJHLX632 route product structure diagram
    ACJHLX63285386-85-2In Stock
Inquiry

Comments (0)